CD163 and metabolic dysfunction-associated steatohepatitis: Of note, sCD163 was not significantly higher in the patients with NASH [1.69 (1.19–2.4) vs. 1.52 (1.15–2.24) mg/L, p = 0.43] in the Italian cohort.